[HTML][HTML] COVID-19. Biology, pathophysiology, and immunology: a pathologist view
M Chilosi, C Doglioni, C Ravaglia, S Piciucchi… - Pathologica, 2023 - ncbi.nlm.nih.gov
Even if the SARS-CoV-2 pandemic has been declared over, several risks and clinical
problems remain to be faced, including long-COVID sequelae and possible outbreaks of …
problems remain to be faced, including long-COVID sequelae and possible outbreaks of …
Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new member of the
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …
[HTML][HTML] SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network
BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was
confirmed in Brazil in February 2020, the first cases were followed by an increase in the …
confirmed in Brazil in February 2020, the first cases were followed by an increase in the …
Clinical characteristics and laboratory parameters associated with the risk of severe COVID-19 in patients from two hospitals in Northeast Brazil
SLM Araújo, TA Feitosa, VC Pereira… - Revista da Sociedade …, 2022 - SciELO Brasil
Background: Although most coronavirus disease 2019 (COVID-19) infections are mild, some
patients have severe clinical conditions requiring hospitalization. Data on the severity of …
patients have severe clinical conditions requiring hospitalization. Data on the severity of …
Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection
The outbreak of coronavirus disease 2019 (COVID‐19) and pandemic, caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has become a major concern …
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has become a major concern …
COVID-19: a systematic review of the transmissibility, pathogenesis, entry factors, and signature immune response
D Fayyad, JL Kelts, TH Nielson, IL Epelle, NC Monear… - BioChem, 2022 - mdpi.com
Objectives: The emergence of coronavirus disease 2019 (COVID-19), caused by the novel
coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a …
coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a …
[HTML][HTML] Severe COVID-19: what have we learned with the immunopathogenesis?
B Bordallo, M Bellas, AF Cortez, M Vieira… - Advances in …, 2020 - SciELO Brasil
The COVID-19 outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has become a global major concern. In this review, we addressed a theoretical …
CoV-2) has become a global major concern. In this review, we addressed a theoretical …
[PDF][PDF] Dysregulation of the immune system as a driver of the critical course of novel coronavirus disease 2019
A Kosmaczewska, I Frydecka - Pol Arch Intern Med, 2020 - scholar.archive.org
AbsTRACT Novel coronavirus disease 2019 (COVID‑19) is a highly contagious, respiratory
disease caused by the newly emerged severe acute respiratory syndrome coronavirus 2 …
disease caused by the newly emerged severe acute respiratory syndrome coronavirus 2 …
Immune response and cytokine storm in SARS-CoV-2 infection: Risk factors, ways of control and treatment
H Chegni, H Babaii, ZM Hassan… - European Journal of …, 2022 - journals.sagepub.com
In 2020, a deadly pandemic caused by the SARS-COV-2 virus spread worldwide and killed
many people. In some viral infections, in addition to the pathogenic role of the virus …
many people. In some viral infections, in addition to the pathogenic role of the virus …
Immunological evaluation of patients with 2019 novel coronavirus pneumonia: CD4+ and CD16+ cells may predict severity and prognosis
S Alahyari, M Rajaeinejad, H Jalaeikhoo, L Chegini… - Plos one, 2022 - journals.plos.org
Purpose Available but insufficient evidence shows that changes may occur in the immune
system following coronavirus disease 2019 (COVID-19). The present study aimed at …
system following coronavirus disease 2019 (COVID-19). The present study aimed at …